Risk factors for post-ERCP pancreatitis: A systematic review and meta-analysis

被引:189
作者
Ding, Xiang [1 ]
Zhang, FuCheng [2 ]
Wang, YaoJun [2 ]
机构
[1] Liaoning Med Univ, Jinan Mil Command, Gen Hosp, Postgrad Training Base, Jinan, Shandong, Peoples R China
[2] Jinan Mil Command, Gen Hosp, Dept Gastroenterol, Jinan 250031, Shandong, Peoples R China
来源
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND | 2015年 / 13卷 / 04期
关键词
Endoscopic retrograde cholangiopancreatography; ERCP; PEP; Post-ERCP pancreatitis; Risk factor; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; DIFFICULT BILIARY CANNULATION; PROSPECTIVE MULTICENTER; CLINICAL-TRIALS; THERAPEUTIC ERCP; STENT PLACEMENT; DUCT STENT; COMPLICATIONS; SPHINCTEROTOMY; SOMATOSTATIN;
D O I
10.1016/j.surge.2014.11.005
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Background and aim: Pancreatitis is the most common and serious complication of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography (ERCP). Prevention strategies targeting risk factors could be important to reduce the rate of post-ERCP pancreatitis. However, the risk factors for post-ERCP pancreatitis (PEP) are still debated. This systematic review and meta-analysis was performed to identify risk factors for PEP. Methods: Medline (PubMed and Ovid), Cochrane Central Register of Controlled trials & Database of Systematic Reviews, Embase, Scopus, ScienceDirect, Springer links and WEB OF SCIENCE were searched for published studies in all languages. Inclusion and exclusion criteria were defined a priori. Eighteen probable risk factors were evaluated, and outcomes were expressed in the case of dichotomous variables, as an odds ratio (OR) (with a 95% confidence interval, (CI)). Results: When patient-related risk factors were analyzed, the ORs for female gender was 1.46 (95%CI: 1.30-1.64); for previous pancreatitis 2.03 (95%CI: 1.31-3.14); for previous PEP was 2.90 (95%CI: 1.87-4.48); for Sphincter of Oddi dysfunction (SOD) was 2.04 (95%CI: 1.73-2.33) and for Intraductal papillary mucinous neoplasm (IPMN) was 3.01 (95%CI: 1.34-6.77). Four endoscopy-related factors were confirmed: the OR for difficult cannulation was 3.49 (95%CI: 1.364-8.925); for endoscopic sphincterotomy (EST) it was 1.39 (95%CI: 1.09-1.79); for precut sphincterotomy it was 2.25 (95%CI: 1.70_2.96); and for main pancreatic duct injection it was 1.58 (95%CI: 1.21-2.08). Conclusions: Female gender, previous pancreatitis, previous PEP, SOD, IPMN, difficult cannulation, EST, precut sphincterotomy and main pancreatic duct injection are risk factors for post-ERCP pancreatitis. (C) 2014 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:218 / 229
页数:12
相关论文
共 43 条
[1]
Mechanism of pancreatitis caused by ERCP [J].
Akashi, R ;
Kiyozumi, T ;
Tanaka, T ;
Sakurai, K ;
Oda, Y ;
Sagara, K .
GASTROINTESTINAL ENDOSCOPY, 2002, 55 (01) :50-54
[2]
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial [J].
Andriulli, A ;
Clemente, R ;
Solmi, L ;
Terruzzi, V ;
Suriani, R ;
Sigillito, A ;
Leandro, G ;
Leo, P ;
De Maio, G ;
Perri, F .
GASTROINTESTINAL ENDOSCOPY, 2002, 56 (04) :488-495
[3]
Incidence rates of post-ERCP complications: A systematic survey of prospective studies [J].
Andriulli, Angelo ;
Loperfido, Silvano ;
Napolitano, Grazia ;
Niro, Grazia ;
Valvano, Maria Rosa ;
Spirito, Fulvio ;
Pilotto, Alberto ;
Forlano, Rosario .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (08) :1781-1788
[4]
Prophylaxis of ERCP-Related Pancreatitis: A Randomized, Controlled Trial of Somatostatin and Gabexate Mesylate [J].
Andriulli, Angelo ;
Solmi, Luigi ;
Loperfido, Silvano ;
Leo, Pietro ;
Festa, Virginia ;
Belmonte, Angelo ;
Spirito, Fulvio ;
Silla, Michele ;
Forte, Giovambattista ;
Terruzzi, Vittorio ;
Marenco, Giorgio ;
Ciliberto, Enrico ;
Sabatino, Antonio ;
Monica, Fabio ;
Magnolia, Maria Rita ;
Perri, Francesco .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (08) :713-718
[5]
Arnelo U, 2014, LIVER INT
[6]
Pancreatits after endoscopic retrograde cholangio-pancreatography [J].
Aziz, Ayman M. Abdel ;
Lehman, Glen A. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (19) :2655-2668
[7]
Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years [J].
Chen, Jian-Jun ;
Wang, Xi-Mo ;
Liu, Xing-Qiang ;
Li, Wen ;
Dong, Mo ;
Suo, Zong-Wu ;
Ding, Po ;
Li, Yue .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2014, 19
[8]
Risk factors for post-ERCP pancreatitis: A prospective multicenter study [J].
Cheng, CL ;
Sherman, S ;
Watkins, JL ;
Barnett, J ;
Freeman, M ;
Geenen, J ;
Ryan, M ;
Parker, H ;
Frakes, JT ;
Fogel, EL ;
Silverman, WB ;
Dua, KS ;
Aliperti, G ;
Yakshe, P ;
Uzer, M ;
Jones, W ;
Goff, J ;
Lazzell-Pannell, L ;
Rashdan, A ;
Temkit, M ;
Lehman, GA .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (01) :139-147
[9]
Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis [J].
Choi, Cheol Woong ;
Kang, Dae Hwan ;
Kim, Gwang Ha ;
Eum, Jae Sup ;
Lee, Sun Mi ;
Song, Geun Am ;
Kim, Dong Uk ;
Kim, Il Doo ;
Cho, Mong .
GASTROINTESTINAL ENDOSCOPY, 2009, 69 (04) :E11-E18
[10]
Complications of ERCP: a prospective study [J].
Christensen, M ;
Matzen, P ;
Schulze, S ;
Rosenberg, J .
GASTROINTESTINAL ENDOSCOPY, 2004, 60 (05) :721-731